{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:24:19Z","timestamp":1793154259493,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170987, 32471047"],"award-info":[{"award-number":["32170987, 32471047"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271039"],"award-info":[{"award-number":["32271039"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MOE Key Laboratory of Geriatric Diseases and Immunology","award":["JYN202401"],"award-info":[{"award-number":["JYN202401"]}]},{"DOI":"10.13039\/501100004610","name":"Science and Technology Support Program of Jiangsu Province","doi-asserted-by":"publisher","award":["CXZX202231"],"award-info":[{"award-number":["CXZX202231"]}],"id":[{"id":"10.13039\/501100004610","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Suzhou International Joint Laboratory for Diagnosis and Treatment of Brain Diseases, the Interdisciplinary Basic Frontier Innovation Program of Suzhou Medical College of Soochow University","award":["YXY2303023"],"award-info":[{"award-number":["YXY2303023"]}]},{"DOI":"10.13039\/100016086","name":"Key Laboratory in Science and Technology Development Project of Suzhou","doi-asserted-by":"publisher","award":["SZ2024001"],"award-info":[{"award-number":["SZ2024001"]}],"id":[{"id":"10.13039\/100016086","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-025-05660-6","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T07:53:01Z","timestamp":1744012381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Loss of NgBR causes neuronal damage through decreasing KAT7-mediated RFX1 acetylation and FGF1 expression"],"prefix":"10.1007","volume":"82","author":[{"given":"Yuwei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanni","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lele","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beisha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8844-4754","authenticated-orcid":false,"given":"Haigang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"issue":"1","key":"5660_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","volume":"75","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Bloem BR (2018) The Parkinson Pandemic\u2014A call to action. JAMA Neurol 75(1):9\u201310. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3299","journal-title":"JAMA Neurol"},{"issue":"6","key":"5660_CR2","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: A review. JAMA 323(6):548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"issue":"6","key":"5660_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1474-4422(18)30127-3","volume":"17","author":"J Marinus","year":"2018","unstructured":"Marinus J, Zhu K, Marras C, Aarsland D, van Hilten JJ (2018) Risk factors for non-motor symptoms in Parkinson\u2019s disease. Lancet Neurol 17(6):559\u2013568. https:\/\/doi.org\/10.1016\/S1474-4422(18)30127-3","journal-title":"Lancet Neurol"},{"issue":"3","key":"5660_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s12264-022-00957-z","volume":"39","author":"R Wang","year":"2023","unstructured":"Wang R, Ren H, Kaznacheyeva E, Lu X, Wang G (2023) Association of glial activation and \u03b1-Synuclein pathology in Parkinson\u2019s disease. Neurosci Bull 39(3):479\u2013490. https:\/\/doi.org\/10.1007\/s12264-022-00957-z","journal-title":"Neurosci Bull"},{"issue":"1","key":"5660_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41588-023-01632-3","volume":"56","author":"T Faial","year":"2024","unstructured":"Faial T (2024) Gene therapy for Parkinson\u2019s disease models. Nat Genet 56(1):8\u20138. https:\/\/doi.org\/10.1038\/s41588-023-01632-3","journal-title":"Nat Genet"},{"key":"5660_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00378-8","author":"S-Y Lim","year":"2024","unstructured":"Lim S-Y, Tan AH, Ahmad-Annuar A et al (2024) Uncovering the genetic basis of Parkinson\u2019s disease globally: from discoveries to the clinic. Lancet Neurol S. https:\/\/doi.org\/10.1016\/S1474-4422(24)00378-8. 1474-4422(24)00378\u20138","journal-title":"Lancet Neurol S"},{"issue":"12","key":"5660_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL et al (2019) Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol 18(12):1091\u20131102. https:\/\/doi.org\/10.1016\/S1474-4422(19)30320-5","journal-title":"Lancet Neurol"},{"issue":"45","key":"5660_CR8","doi-asserted-by":"publisher","first-page":"11567","DOI":"10.1073\/pnas.1809969115","volume":"115","author":"J Guo","year":"2018","unstructured":"Guo J, Zhang L, Li K et al (2018) Coding mutations in NUS1 contribute to Parkinson\u2019s disease. Proc Natl Acad Sci U S A 115(45):11567\u201311572. https:\/\/doi.org\/10.1073\/pnas.1809969115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5660_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neurobiolaging.2021.09.003","volume":"110","author":"L Jiang","year":"2022","unstructured":"Jiang L, Mei J-P, Zhao Y-W et al (2022) Low-frequency and rare coding variants of NUS1 contribute to susceptibility and phenotype of Parkinson\u2019s disease. Neurobiol Aging 110:106\u2013112. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.09.003","journal-title":"Neurobiol Aging"},{"issue":"4","key":"5660_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/WCO.0000000000001167","volume":"36","author":"A Cherian","year":"2023","unstructured":"Cherian A, K P D, Vijayaraghavan A (2023) Parkinson\u2019s disease - genetic cause. Curr Opin Neurol 36(4):292\u2013301. https:\/\/doi.org\/10.1097\/WCO.0000000000001167","journal-title":"Curr Opin Neurol"},{"key":"5660_CR11","doi-asserted-by":"publisher","unstructured":"Park EJ, Sessa WC (2012) NogoB receptor is essential for extraembryonic vascular development and protein glycosylation. FASEB J 26(S1). https:\/\/doi.org\/10.1096\/fasebj.26.1_supplement.607.5. 607.5-607.5","DOI":"10.1096\/fasebj.26.1_supplement.607.5"},{"issue":"7","key":"5660_CR12","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41436-021-01137-6","volume":"23","author":"S-H Yu","year":"2021","unstructured":"Yu S-H, Wang T, Wiggins K et al (2021) Lysosomal cholesterol accumulation contributes to the movement phenotypes associated with NUS1 haploinsufficiency. Genet Med 23(7):1305\u20131314. https:\/\/doi.org\/10.1038\/s41436-021-01137-6","journal-title":"Genet Med"},{"issue":"1","key":"5660_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/mdc3.13920","volume":"11","author":"LJ Williams","year":"2024","unstructured":"Williams LJ, Waller S, Qiu J et al (2024) DHDDS and NUS1: A converging pathway and common phenotype. Mov Disord Clin Pract 11(1):76\u201385. https:\/\/doi.org\/10.1002\/mdc3.13920","journal-title":"Mov Disord Clin Pract"},{"issue":"14","key":"5660_CR14","doi-asserted-by":"publisher","first-page":"7697","DOI":"10.1111\/jcmm.15391","volume":"24","author":"R Zhang","year":"2020","unstructured":"Zhang R, Tang B-S, Guo J-F (2020) Research advances on neurite outgrowth inhibitor B receptor. J Cell Mol Med 24(14):7697\u20137705. https:\/\/doi.org\/10.1111\/jcmm.15391","journal-title":"J Cell Mol Med"},{"key":"5660_CR15","doi-asserted-by":"publisher","first-page":"106371","DOI":"10.1016\/j.eplepsyres.2020.106371","volume":"164","author":"K Araki","year":"2020","unstructured":"Araki K, Nakamura R, Ito D et al (2020) NUS1 mutation in a family with epilepsy, cerebellar ataxia, and tremor. Epilepsy Res 164:106371. https:\/\/doi.org\/10.1016\/j.eplepsyres.2020.106371","journal-title":"Epilepsy Res"},{"issue":"10","key":"5660_CR16","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1038\/s41401-023-01104-8","volume":"44","author":"L Liu","year":"2023","unstructured":"Liu L, Han Y, Zhang Z et al (2023) Loss of DJ-1 function contributes to Parkinson\u2019s disease pathogenesis in mice via RACK1-mediated PKC activation and MAO-B upregulation. Acta Pharmacol Sin 44(10):1948\u20131961. https:\/\/doi.org\/10.1038\/s41401-023-01104-8","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"5660_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41401-018-0064-0","volume":"40","author":"D-K Guo","year":"2019","unstructured":"Guo D-K, Zhu Y, Sun H-Y et al (2019) Pharmacological activation of REV-ERB\u03b1 represses LPS-induced microglial activation through the NF-\u03baB pathway. Acta Pharmacol Sin 40(1):26\u201334. https:\/\/doi.org\/10.1038\/s41401-018-0064-0","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"5660_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41419-021-04002-1","volume":"12","author":"Z Lin","year":"2021","unstructured":"Lin Z, Chen C, Yang D, Ding J, Wang G, Ren H (2021) DJ-1 inhibits microglial activation and protects dopaminergic neurons in vitro and in vivo through interacting with microglial p65. Cell Death Dis 12(8):715. https:\/\/doi.org\/10.1038\/s41419-021-04002-1","journal-title":"Cell Death Dis"},{"issue":"1","key":"5660_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13023-022-02348-z","volume":"17","author":"J Chen","year":"2022","unstructured":"Chen J, Ma Y, Li H et al (2022) Rare and potential pathogenic mutations of LMNA and LAMA4 associated with Familial arrhythmogenic right ventricular cardiomyopathy\/dysplasia with right ventricular heart failure, cerebral thromboembolism and hereditary electrocardiogram abnormality. Orphanet J Rare Dis 17(1):183. https:\/\/doi.org\/10.1186\/s13023-022-02348-z","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"5660_CR20","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1158\/1535-7163.MCT-16-0848","volume":"16","author":"L Giulino-Roth","year":"2017","unstructured":"Giulino-Roth L, van Besien HJ, Dalton T et al (2017) Inhibition of Hsp90 suppresses PI3K\/AKT\/mTOR signaling and has antitumor activity in Burkitt lymphoma. Mol Cancer Ther 16(9):1779\u20131790. https:\/\/doi.org\/10.1158\/1535-7163.MCT-16-0848","journal-title":"Mol Cancer Ther"},{"key":"5660_CR21","doi-asserted-by":"publisher","unstructured":"Ali NH, Al-Kuraishy HM, Al-Gareeb AI, Alnaaim SA, Saad HM, Batiha GE-S (2023) The molecular pathway of p75 neurotrophin receptor (p75NTR) in Parkinson\u2019s disease: the way of new inroads. https:\/\/doi.org\/10.1007\/s12035-023-03727-8. Mol Neurobiol","DOI":"10.1007\/s12035-023-03727-8"},{"issue":"8","key":"5660_CR22","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1007\/s12035-021-02367-0","volume":"58","author":"L Klimaschewski","year":"2021","unstructured":"Klimaschewski L, Claus P (2021) Fibroblast growth factor signalling in the diseased nervous system. Mol Neurobiol 58(8):3884\u20133902. https:\/\/doi.org\/10.1007\/s12035-021-02367-0","journal-title":"Mol Neurobiol"},{"issue":"3","key":"5660_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/dneu.22225","volume":"75","author":"M-S Chen","year":"2015","unstructured":"Chen M-S, Lin H-K, Chiu H, Lee D-C, Chung Y-F, Chiu I-M (2015) Human FGF1 promoter is active in ependymal cells and dopaminergic neurons in the brains of F1B-GFP Transgenic mice. Dev Neurobiol 75(3):232\u2013248. https:\/\/doi.org\/10.1002\/dneu.22225","journal-title":"Dev Neurobiol"},{"key":"5660_CR24","doi-asserted-by":"publisher","first-page":"105596","DOI":"10.1016\/j.phrs.2021.105596","volume":"169","author":"M Xiao","year":"2021","unstructured":"Xiao M, Tang Y, Wang AJ et al (2021) Regulatory role of endogenous and exogenous fibroblast growth factor 1 in the cardiovascular system and related diseases. Pharmacol Res 169:105596. https:\/\/doi.org\/10.1016\/j.phrs.2021.105596","journal-title":"Pharmacol Res"},{"issue":"2","key":"5660_CR25","first-page":"341","volume":"8","author":"RL Myers","year":"1993","unstructured":"Myers RL, Payson RA, Chotani MA, Deaven LL, Chiu IM (1993) Gene structure and differential expression of acidic fibroblast growth factor mRNA: identification and distribution of four different transcripts. Oncogene 8(2):341\u2013349","journal-title":"Oncogene"},{"issue":"18","key":"5660_CR26","doi-asserted-by":"publisher","first-page":"13885","DOI":"10.1074\/jbc.M109.081463","volume":"285","author":"Y-C Hsu","year":"2010","unstructured":"Hsu Y-C, Liao W-C, Kao C-Y, Chiu I-M (2010) Regulation of FGF1 gene promoter through transcription factor RFX1. J Biol Chem 285(18):13885\u201313895. https:\/\/doi.org\/10.1074\/jbc.M109.081463","journal-title":"J Biol Chem"},{"issue":"7","key":"5660_CR27","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1002\/jcb.24127","volume":"113","author":"Y-C Hsu","year":"2012","unstructured":"Hsu Y-C, Kao C-Y, Chung Y-F, Chen M-S, Chiu I-M (2012) Ciliogenic RFX transcription factors regulate FGF1 gene promoter. J Cell Biochem 113(7):2511\u20132522. https:\/\/doi.org\/10.1002\/jcb.24127","journal-title":"J Cell Biochem"},{"issue":"1","key":"5660_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00018-024-05262-8","volume":"81","author":"L Clausen","year":"2024","unstructured":"Clausen L, Okarmus J, Voutsinos V, Meyer M, Lindorff-Larsen K, Hartmann-Petersen R (2024) PRKN-linked Familial Parkinson\u2019s disease: cellular and molecular mechanisms of disease-linked variants. Cell Mol Life Sci 81(1):223. https:\/\/doi.org\/10.1007\/s00018-024-05262-8","journal-title":"Cell Mol Life Sci"},{"key":"5660_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2016.06.003","volume":"169","author":"Y Guo","year":"2016","unstructured":"Guo Y, Zhao M, Lu Q (2016) Transcription factor RFX1 is ubiquitinated by E3 ligase STUB1 in systemic lupus erythematosus. Clin Immunol 169:1\u20137. https:\/\/doi.org\/10.1016\/j.clim.2016.06.003","journal-title":"Clin Immunol"},{"issue":"1","key":"5660_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41467-023-35795-8","volume":"14","author":"JM Lee","year":"2023","unstructured":"Lee JM, Hammar\u00e9n HM, Savitski MM, Baek SH (2023) Control of protein stability by post-translational modifications. Nat Commun 14(1):201. https:\/\/doi.org\/10.1038\/s41467-023-35795-8","journal-title":"Nat Commun"},{"issue":"14","key":"5660_CR31","doi-asserted-by":"publisher","first-page":"9260","DOI":"10.1074\/jbc.M511724200","volume":"281","author":"Y Xu","year":"2006","unstructured":"Xu Y, Sengupta PK, Seto E, Smith BD (2006) RFX family proteins differentially interact with HDACs to repress collagen alpha 2(I) gene (COL1A2) expression. J Biol Chem 281(14):9260\u20139270. https:\/\/doi.org\/10.1074\/jbc.M511724200","journal-title":"J Biol Chem"},{"issue":"2","key":"5660_CR32","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jid.2016.09.027","volume":"137","author":"SA Best","year":"2017","unstructured":"Best SA, Nwaobasi AN, Schmults CD, Ramsey MR (2017) CCAR2 is required for proliferation and tumor maintenance in human squamous cell carcinoma. J Invest Dermatology 137(2):506\u2013512. https:\/\/doi.org\/10.1016\/j.jid.2016.09.027","journal-title":"J Invest Dermatology"},{"issue":"19","key":"5660_CR33","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.3390\/ijms21197182","volume":"21","author":"R Wang","year":"2020","unstructured":"Wang R, Sun H, Wang G, Ren H (2020) Imbalance of lysine acetylation contributes to the pathogenesis of Parkinson\u2019s disease. Int J Mol Sci 21(19):7182. https:\/\/doi.org\/10.3390\/ijms21197182","journal-title":"Int J Mol Sci"},{"issue":"9","key":"5660_CR34","doi-asserted-by":"publisher","first-page":"e151382","DOI":"10.1172\/JCI151382","volume":"132","author":"Z Fang","year":"2022","unstructured":"Fang Z, Sun X, Wang X et al (2022) NOGOB receptor deficiency increases cerebrovascular permeability and hemorrhage via impairing histone acetylation-mediated CCM1\/2 expression. J Clin Invest 132(9):e151382. https:\/\/doi.org\/10.1172\/JCI151382","journal-title":"J Clin Invest"},{"key":"5660_CR35","doi-asserted-by":"publisher","first-page":"1373448","DOI":"10.3389\/fgene.2024.1373448","volume":"15","author":"R Li","year":"2024","unstructured":"Li R, Yang J, Ma J, Zhang A, Li H (2024) Case report: novel NUS1 variant in a Chinese patient with tremors and intellectual disability. Front Genet 15:1373448. https:\/\/doi.org\/10.3389\/fgene.2024.1373448","journal-title":"Front Genet"},{"key":"5660_CR36","doi-asserted-by":"publisher","unstructured":"Chen X, Xiao Y, Zhou M et al (2020) Genetic analysis of NUS1 in Chinese patients with Parkinson\u2019s disease. Neurobiol Aging 86. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.09.002.:202.e5-202.e6","DOI":"10.1016\/j.neurobiolaging.2019.09.002"},{"issue":"7","key":"5660_CR37","doi-asserted-by":"publisher","first-page":"e22411","DOI":"10.1096\/fj.202200212R","volume":"36","author":"J Xue","year":"2022","unstructured":"Xue J, Zhu Y, Wei L et al (2022) Loss of drosophila NUS1 results in cholesterol accumulation and Parkinson\u2019s disease-related neurodegeneration. FASEB J 36(7):e22411. https:\/\/doi.org\/10.1096\/fj.202200212R","journal-title":"FASEB J"},{"issue":"9","key":"5660_CR38","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1523\/JNEUROSCI.22-09-03553.2002","volume":"22","author":"AB Huber","year":"2002","unstructured":"Huber AB, Weinmann O, Br\u00f6samle C, Oertle T, Schwab ME (2002) Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci 22(9):3553\u20133567. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-09-03553.2002","journal-title":"J Neurosci"},{"issue":"6","key":"5660_CR39","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s42255-022-00580-2","volume":"4","author":"E Gasser","year":"2022","unstructured":"Gasser E, Sancar G, Downes M, Evans RM (2022) Metabolic messengers: fibroblast growth factor 1. Nat Metab 4(6):663\u2013671. https:\/\/doi.org\/10.1038\/s42255-022-00580-2","journal-title":"Nat Metab"},{"issue":"3","key":"5660_CR40","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.mcn.2009.04.010","volume":"41","author":"D-C Lee","year":"2009","unstructured":"Lee D-C, Hsu Y-C, Chung Y-F et al (2009) Isolation of neural stem\/progenitor cells by using EGF\/FGF1 and FGF1B promoter-driven green fluorescence from embryonic and adult mouse brains. Mol Cell Neurosci 41(3):348\u2013363. https:\/\/doi.org\/10.1016\/j.mcn.2009.04.010","journal-title":"Mol Cell Neurosci"},{"key":"5660_CR41","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1749-6632.1991.tb49045.x","volume":"638","author":"F Eckenstein","year":"1991","unstructured":"Eckenstein F, Woodward WR, Nishi R (1991) Differential localization and possible functions of aFGF and bFGF in the central and peripheral nervous systems. Ann N Y Acad Sci 638:348\u2013360. https:\/\/doi.org\/10.1111\/j.1749-6632.1991.tb49045.x","journal-title":"Ann N Y Acad Sci"},{"key":"5660_CR42","doi-asserted-by":"publisher","first-page":"675725","DOI":"10.3389\/fphar.2021.675725","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Deng J, Liu Y, Li W, Nie X (2021) FGF, mechanism of action, role in Parkinson\u2019s disease, and therapeutics. Front Pharmacol 12:675725. https:\/\/doi.org\/10.3389\/fphar.2021.675725","journal-title":"Front Pharmacol"},{"issue":"42","key":"5660_CR43","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.1038\/sj.onc.1203872","volume":"19","author":"M Bryckaert","year":"2000","unstructured":"Bryckaert M, Guillonneau X, Hecquet C, Perani P, Courtois Y, Mascarelli F (2000) Regulation of proliferation-survival decisions is controlled by FGF1 secretion in retinal pigmented epithelial cells. Oncogene 19(42):4917\u20134929. https:\/\/doi.org\/10.1038\/sj.onc.1203872","journal-title":"Oncogene"},{"issue":"35","key":"5660_CR44","doi-asserted-by":"publisher","first-page":"22367","DOI":"10.1074\/jbc.273.35.22367","volume":"273","author":"X Guillonneau","year":"1998","unstructured":"Guillonneau X, Bryckaert M, Launay-Longo C, Courtois Y, Mascarelli F (1998) Endogenous FGF1-induced activation and synthesis of extracellular Signal-regulated kinase 2 reduce cell apoptosis in Retinal-pigmented epithelial cells*. J Biol Chem 273(35):22367\u201322373. https:\/\/doi.org\/10.1074\/jbc.273.35.22367","journal-title":"J Biol Chem"},{"key":"5660_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-01902-7","author":"T Xie","year":"2022","unstructured":"Xie T, Du K, Liu W et al (2022) LHX2 facilitates the progression of nasopharyngeal carcinoma via activation of the FGF1\/FGFR axis. Br J Cancer. https:\/\/doi.org\/10.1038\/s41416-022-01902-7","journal-title":"Br J Cancer"},{"issue":"7","key":"5660_CR46","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41419-022-04994-4","volume":"13","author":"C Eggermont","year":"2022","unstructured":"Eggermont C, Giron P, Noeparast M et al (2022) The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer. Cell Death Dis 13(7):611. https:\/\/doi.org\/10.1038\/s41419-022-04994-4","journal-title":"Cell Death Dis"},{"issue":"5","key":"5660_CR47","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.3892\/ijo.2018.4520","volume":"53","author":"Y-K Li","year":"2018","unstructured":"Li Y-K, Xie Y-J, Wu D-C, Long S-L, Tang S, Mo Z-C (2018) Nogo\u2013B receptor in relevant carcinoma: current achievements, challenges and aims (Review). Int J Oncol 53(5):1827\u20131835. https:\/\/doi.org\/10.3892\/ijo.2018.4520","journal-title":"Int J Oncol"},{"issue":"24","key":"5660_CR48","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1182\/blood-2010-02-271577","volume":"116","author":"B Zhao","year":"2010","unstructured":"Zhao B, Chun C, Liu Z et al (2010) Nogo-B receptor is essential for angiogenesis in zebrafish via Akt pathway. Blood 116(24):5423\u20135433. https:\/\/doi.org\/10.1182\/blood-2010-02-271577","journal-title":"Blood"},{"key":"5660_CR49","doi-asserted-by":"publisher","unstructured":"Rodriguez-Enfedaque A, Bouleau S, Laurent M et al (2009) FGF1 nuclear translocation is required for both its neurotrophic activity and its p53-dependent apoptosis protection. Biochimica et biophysica acta (BBA) -. Mol Cell Res 1793(11):1719\u20131727. https:\/\/doi.org\/10.1016\/j.bbamcr.2009.09.010","DOI":"10.1016\/j.bbamcr.2009.09.010"},{"issue":"2","key":"5660_CR50","doi-asserted-by":"publisher","first-page":"e2079","DOI":"10.1038\/cddis.2016.2","volume":"7","author":"E Delmas","year":"2016","unstructured":"Delmas E, Jah N, Pirou C et al (2016) FGF1 C-terminal domain and phosphorylation regulate intracrine FGF1 signaling for its neurotrophic and anti-apoptotic activities. Cell Death Dis 7(2):e2079. https:\/\/doi.org\/10.1038\/cddis.2016.2","journal-title":"Cell Death Dis"},{"issue":"8","key":"5660_CR51","doi-asserted-by":"publisher","first-page":"e3023","DOI":"10.1038\/cddis.2017.404","volume":"8","author":"C Pirou","year":"2017","unstructured":"Pirou C, Montazer-Torbati F, Jah N et al (2017) FGF1 protects neuroblastoma SH-SY5Y cells from p53-dependent apoptosis through an intracrine pathway regulated by FGF1 phosphorylation. Cell Death Dis 8(8):e3023. https:\/\/doi.org\/10.1038\/cddis.2017.404","journal-title":"Cell Death Dis"},{"issue":"6","key":"5660_CR52","first-page":"664","volume":"6","author":"X Wei","year":"2014","unstructured":"Wei X, He S, Wang Z et al (2014) Fibroblast growth factor 1attenuates 6-hydroxydopamine-induced neurotoxicity: an in vitro and in vivo investigation in experimental models of Parkinson\u2019s disease. Am J Transl Res 6(6):664\u2013677","journal-title":"Am J Transl Res"},{"issue":"1","key":"5660_CR53","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0006-8993(90)90264-c","volume":"526","author":"I Date","year":"1990","unstructured":"Date I, Notter MF, Felten SY, Felten DL (1990) MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF). Brain Res 526(1):156\u2013160. https:\/\/doi.org\/10.1016\/0006-8993(90)90264-c","journal-title":"Brain Res"},{"issue":"3","key":"5660_CR54","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/BF03033263","volume":"3","author":"RN McLay","year":"2001","unstructured":"McLay RN, Freeman SM, Zadina JE (2001) Administration of FGF-1 through transfected cells alleviates MPTP toxicity in mice. Neurotox Res 3(3):249\u2013253. https:\/\/doi.org\/10.1007\/BF03033263","journal-title":"Neurotox Res"},{"issue":"2","key":"5660_CR55","doi-asserted-by":"publisher","first-page":"344","DOI":"10.5603\/fhc.2011.0047","volume":"49","author":"C Feng","year":"2011","unstructured":"Feng C, Li J, Zuo Z (2011) Expression of the transcription factor regulatory factor X1 in the mouse brain. Folia Histochem Cytobiol 49(2):344\u2013351. https:\/\/doi.org\/10.5603\/fhc.2011.0047","journal-title":"Folia Histochem Cytobiol"},{"issue":"45","key":"5660_CR56","doi-asserted-by":"publisher","first-page":"35200","DOI":"10.1074\/jbc.M004838200","volume":"275","author":"M Sharma","year":"2000","unstructured":"Sharma M, Zarnegar M, Li X, Lim B, Sun Z (2000) Androgen receptor interacts with a novel MYST protein, HBO1. J Biol Chem 275(45):35200\u201335208. https:\/\/doi.org\/10.1074\/jbc.M004838200","journal-title":"J Biol Chem"},{"issue":"9","key":"5660_CR57","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1074\/jbc.RA117.000529","volume":"293","author":"Z Han","year":"2018","unstructured":"Han Z, Wu H, Kim S et al (2018) Revealing the protein propionylation activity of the histone acetyltransferase MOF (males absent on the first). J Biol Chem 293(9):3410\u20133420. https:\/\/doi.org\/10.1074\/jbc.RA117.000529","journal-title":"J Biol Chem"},{"issue":"7","key":"5660_CR58","doi-asserted-by":"publisher","first-page":"498","DOI":"10.2183\/pjab.93.030","volume":"93","author":"M Iizuka","year":"2017","unstructured":"Iizuka M, Susa T, Tamamori-Adachi M, Okinaga H, Okazaki T (2017) Intrinsic ubiquitin E3 ligase activity of histone acetyltransferase Hbo1 for Estrogen receptor \u03b1. Proc Jpn Acad Ser B Phys Biol Sci 93(7):498\u2013510. https:\/\/doi.org\/10.2183\/pjab.93.030","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"4","key":"5660_CR59","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00018-019-03296-x","volume":"77","author":"R Lan","year":"2020","unstructured":"Lan R, Wang Q (2020) Deciphering structure, function and mechanism of lysine acetyltransferase HBO1 in protein acetylation, transcription regulation, DNA replication and its oncogenic properties in cancer. Cell Mol Life Sci 77(4):637\u2013649. https:\/\/doi.org\/10.1007\/s00018-019-03296-x","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"5660_CR60","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.celrep.2016.12.052","volume":"18","author":"S Uchida","year":"2017","unstructured":"Uchida S, Teubner BJW, Hevi C et al (2017) CRTC1 nuclear translocation following learning modulates memory strength via exchange of chromatin remodeling complexes on the Fgf1 gene. Cell Rep 18(2):352\u2013366. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.052","journal-title":"Cell Rep"},{"key":"5660_CR61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.brainresbull.2018.02.016","volume":"141","author":"S Uchida","year":"2018","unstructured":"Uchida S, Shumyatsky GP (2018) Epigenetic regulation of Fgf1 transcription by CRTC1 and memory enhancement. Brain Res Bull 141:3\u201312. https:\/\/doi.org\/10.1016\/j.brainresbull.2018.02.016","journal-title":"Brain Res Bull"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05660-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05660-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05660-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T07:53:14Z","timestamp":1744012394000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05660-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5660"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05660-6","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments performed in this study were in accordance with the institutional guidelines for the use and care of animals, and all procedures were approved by the Institute Animal Welfare Committee of Soochow University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors reviewed the results and contributed to the final manuscript. All authors approved this manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest with the contents of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}